Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 1 (KRT8P1) is classified as a processed pseudogene related to the keratin 8 gene (KRT8), a type II intermediate filament protein expressed in epithelial cells[5][7]. Unlike the functional KRT8 gene, which encodes a protein involved in maintaining structural integrity and signal transduction in epithelial cells, KRT8P1 does not produce a functional protein. It is a noncoding DNA sequence present in the human genome, likely arising through gene duplication or retrotransposition events, and is generally considered nonfunctional. Pseudogenes like KRT8P1 are not categorized as drug targets or disease genes and are not involved in cellular or molecular functions[5][7]. Note: If a therapeutic or diagnostic context for KRT8P1 is claimed, there may be an error or confusion with the functional protein-coding gene "Keratin 8 (KRT8)", which is a marker in liver and cancer pathology, but this does not apply to KRT8 pseudogenes[2][3][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 1 (KRT8P1).